Literature DB >> 11819544

Expression of IGF- II, p53, p21 and HBxAg in precancerous events of hepatocarcinogenesis induced by AFB1 and/or HBV in tree shrews.

Liu-Liang Qin, Jian-Jia Su, Yuan Li, Chun Yang, Ke-Chen Ban, Rue-Qi Yian.   

Abstract

Entities:  

Year:  2000        PMID： 11819544      PMCID： PMC4723584          DOI： 10.3748/wjg.v6.i1.138

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  2 in total

1.  Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and immunocytochemistry.

Authors:  D Y Yang; C E Rogler
Journal:  Carcinogenesis       Date:  1991-10       Impact factor: 4.944

2.  Different mutations of the p53 gene in nodule-in-nodule hepatocellular carcinoma as a evidence for multistage progression.

Authors:  T Oda; H Tsuda; M Sakamoto; S Hirohashi
Journal:  Cancer Lett       Date:  1994-08-15       Impact factor: 8.679
  2 in total
  9 in total

1.  Chemopreventive effect of oltipraz on AFB(1)-induced hepatocarcinogenesis in tree shrew model.

Authors:  Yuan Li; Jian-Jia Su; Liu-Liang Qin; Chun Yang; Dan Luo; Ke-Chen Ban; TW Kensler; BD Roebuck
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Construction and characterization of an experimental ISCOMS-based hepatitis B polypeptide vaccine.

Authors:  Xiao-Ju Guan; Xiao-Jun Guan; Yu-Zhang Wu; Zheng-Cai Jia; Tong-Dong Shi; Yan Tang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

3.  Expression and bioactivity identification of soluble MG7 scFv.

Authors:  Zhao-Cai Yu; Jie Ding; Bo-Rong Pan; Dai-Ming Fan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

4.  Maxizyme-mediated specific inhibition on mutant-type p53 in vitro.

Authors:  Xin-Juan Kong; Yu-Hu Song; Ju-Sheng Lin; Huan-Jun Huang; Nan-Xia Wang; Nan-Zhi Liu; Bin Li; You-Xin Jin
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

5.  Detection of hepatitis C virus NS5 protein and genome in Chinese carcinoma of the extrahepatic bile duct and its significance.

Authors:  Ming-Yi Chen; Zhi-Qiang Huang; Le-Zhen Chen; Ya-Bing Gao; Rui-Yun Peng; De-Wen Wang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

6.  Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues.

Authors:  Zhao-Shan Niu; Bo-Kian Li; Mei Wang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

7.  Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines.

Authors:  Miao-Wang Hao; Ying-Rui Liang; Yan-Fang Liu; Li Liu; Ming-Yao Wu; Huan-Xing Yang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

8.  Seek protein which can interact with hepatitis B virus X protein from human liver cDNA library by yeast two-hybrid system.

Authors:  Xiao-Zhong Wang; Xiang-Rong Jiang; Xiao-Chun Chen; Zhi-Xing Chen; Dan Li; Jian-Yin Lin; Qi-Min Tao
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

9.  Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system.

Authors:  Xiao-Zhong Wang; Xiao-Chun Chen; Yun-Xin Chen; Li-Juan Zhang; Dan Li; Feng-Lin Chen; Zhi-Xin Chen; Hong-Ying Chen; Qi-Ming Tao
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.